ABOUT THIS EPISODE
Featuring perspectives from Dr Joyce F Liu, Dr David M O'Malley and Dr Brian M Slomovitz, moderated by Dr O'Malley, including the following topic:
- Case: A woman in her late 50s with a BRCA1 germline mutation and platinum- and PARP inhibitor-resistant metastatic ovarian cancer with low folate receptor alpha level and HER2 IHC 1+ — Professor Jonathan A Ledermann
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of Gynecologic Oncology Update.
OTHER EPISODES IN THIS PODCAST
Featuring perspectives from Dr Shannon N Westin and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics:
Introduction (0:00)
Ovarian Cancer (2:22)
Endometrial Cancer (37:48)
CME information and select publications
Featuring perspectives from Dr Rachel N Grisham, including the following topics:
Case: A woman in her early 40s with recurrent low-grade serous ovarian cancer (LGSOC) and prior treatment with a MEK inhibitor receives avutometinib/defactinib on the RAMP 301 trial (0:00)
Case: A woman in her early 7…
Featuring perspectives from Dr Gottfried E Konecny and Dr Brian M Slomovitz, including the following topics:
Introduction (0:00)
Preventing Ovarian Cancer (1:04)
Endometrial Cancer (5:27)
Ovarian Cancer (25:36)
Cervical Cancer (54:04)
CME information and select publications
Featuring an interview with Professor Nicoletta Colombo, including the following topics:
Mechanistic effects and rationale underlying the use of relacorilant/nab paclitaxel (0:00)
Rationale underlying the study design of the Phase II BELLA trial and avenues for future exploration (8:31)
Definition…
Disclaimer: The podcast and artwork embedded on this page are from Dr. Neil Love, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.